Cytokinetics (CYTK) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Cytokinetics Revenue Highlights

Latest Revenue (Y)

$7.53M

Latest Revenue (Q)

$463.00K

Main Segment (Y)

Research And Development

Cytokinetics Revenue by Period

Cytokinetics Revenue by Year

Date	Revenue	Change
2023-12-31	$7.53M	-92.04%
2022-12-31	$94.59M	34.30%
2021-12-31	$70.43M	26.15%
2020-12-31	$55.83M	107.79%
2019-12-31	$26.87M	-14.71%
2018-12-31	$31.50M	135.64%
2017-12-31	$13.37M	-87.44%
2016-12-31	$106.41M	271.30%
2015-12-31	$28.66M	-38.95%
2014-12-31	$46.94M	53.16%
2013-12-31	$30.65M	305.45%
2012-12-31	$7.56M	88.97%
2011-12-31	$4.00M	55.22%
2010-12-31	$2.58M	-96.84%
2009-12-31	$81.54M	556.51%
2008-12-31	$12.42M	-8.82%
2007-12-31	$13.62M	335.63%
2006-12-31	$3.13M	-64.91%
2005-12-31	$8.91M	-33.70%
2004-12-31	$13.44M	27.09%
2003-12-31	$10.58M	-7.19%
2002-12-31	$11.40M	34.61%
2001-12-31	$8.47M	100.00%
2000-12-31	-	-

Cytokinetics generated $7.53M in revenue during NA 2023, up -92.04% compared to the previous quarter, and up 23.90% compared to the same period a year ago.

Cytokinetics Revenue by Quarter

Date	Revenue	Change
2024-09-30	$463.00K	85.94%
2024-06-30	$249.00K	-70.18%
2024-03-31	$835.00K	-50.06%
2023-12-31	$1.67M	342.33%
2023-09-30	$378.00K	-56.40%
2023-06-30	$867.00K	-81.21%
2023-03-31	$4.61M	135.72%
2022-12-31	$1.96M	-22.19%
2022-09-30	$2.52M	-97.17%
2022-06-30	$88.97M	7649.83%
2022-03-31	$1.15M	-97.94%
2021-12-31	$55.60M	922.62%
2021-09-30	$5.44M	91.24%
2021-06-30	$2.84M	-56.58%
2021-03-31	$6.55M	-2.59%
2020-12-31	$6.72M	-83.88%
2020-09-30	$41.69M	1060.26%
2020-06-30	$3.59M	-6.07%
2020-03-31	$3.83M	-26.61%
2019-12-31	$5.21M	-13.92%
2019-09-30	$6.05M	-15.16%
2019-06-30	$7.14M	-15.68%
2019-03-31	$8.46M	-9.74%
2018-12-31	$9.38M	-11.88%
2018-09-30	$10.64M	71.21%
2018-06-30	$6.21M	17.98%
2018-03-31	$5.27M	-29366.67%
2017-12-31	$-18.00K	-100.29%
2017-09-30	$6.18M	102.42%
2017-06-30	$3.05M	-26.49%
2017-03-31	$4.15M	-87.47%
2016-12-31	$33.14M	-43.88%
2016-09-30	$59.05M	917.70%
2016-06-30	$5.80M	-31.10%
2016-03-31	$8.42M	-13.69%
2015-12-31	$9.76M	22.81%
2015-09-30	$7.95M	21.45%
2015-06-30	$6.54M	48.21%
2015-03-31	$4.41M	-79.71%
2014-12-31	$21.76M	131.10%
2014-09-30	$9.41M	20.89%
2014-06-30	$7.79M	-2.39%
2014-03-31	$7.98M	-67.23%
2013-12-31	$24.35M	444.84%
2013-09-30	$4.47M	342.91%
2013-06-30	$1.01M	22.90%
2013-03-31	$821.00K	-62.41%
2012-12-31	$2.18M	27.42%
2012-09-30	$1.71M	-6.90%
2012-06-30	$1.84M	1.15%
2012-03-31	$1.82M	140.42%
2011-12-31	$757.00K	-46.95%
2011-09-30	$1.43M	35.52%
2011-06-30	$1.05M	38.01%
2011-03-31	$763.00K	-30.57%
2010-12-31	$1.10M	178.93%
2010-09-30	$394.00K	-14.72%
2010-06-30	$462.00K	-25.60%
2010-03-31	$621.00K	-39.30%
2009-12-31	$1.02M	-81.42%
2009-09-30	$5.51M	-92.35%
2009-06-30	$71.93M	2236.91%
2009-03-31	$3.08M	-2.35%
2008-12-31	$3.15M	0.86%
2008-09-30	$3.13M	1.66%
2008-06-30	$3.07M	0.16%
2008-03-31	$3.07M	-1.32%
2007-12-31	$3.11M	-

Cytokinetics generated $463.00K in revenue during Q3 2024, up 85.94% compared to the previous quarter, and up 53.40% compared to the same period a year ago.

Cytokinetics Revenue Breakdown

Cytokinetics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Research And Development	$4.03M	$6.59M	$10.57M	$16.53M	-
License	-	-	$36.50M	-	-
Milestone	$3.50M	$1.00M	-	-	-
Research And Development Milestone Grant And Other Revenues Net	-	-	$7.40M	$10.00M	$13.80M
Reimbursements	-	-	-	-	$13.11M
Milestone Fees	-	-	-	-	-

Cytokinetics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Research And Development (53.52%), and Milestone (46.48%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Research And Development	$463.00K	$835.00K	$672.00K	$378.00K	$867.00K	$2.11M	$1.96M	$2.52M	$968.00K	$1.15M	$744.00K	$437.00K	$2.84M	$6.55M	$3.92M	$5.19M	$3.59M	$3.83M	$5.21M	$6.05M
Milestone	-	-	$1.00M	-	-	$2.50M	-	-	$1.00M	-	-	-	-	-	-	-	-	-	-	-
License	-	-	-	-	-	-	-	-	-	-	$54.86M	-	-	-	-	-	-	-	-	-
Milestones	-	-	-	-	-	-	-	-	-	-	-	$5.00M	-	-	-	-	-	-	-	-
Research And Development Milestone Grant And Other Revenues Net	-	-	-	-	-	-	-	-	-	-	-	-	$2.50M	$4.80M	$1.70M	$3.80M	$2.10M	$2.30M	-	-

Cytokinetics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Research And Development (100.00%).

Cytokinetics Revenue Breakdown by Country

Quarterly Revenue by Country

Country	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18
Milestone	-	$2.50M	-	-	$1.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development	$867.00K	$2.11M	$1.96M	$2.52M	$968.00K	$1.15M	$744.00K	$437.00K	$2.84M	$6.55M	$3.92M	$5.19M	$3.59M	$3.83M	$5.21M	$6.05M	$7.14M	$8.46M	-	-
License	-	-	-	-	-	-	$54.86M	-	-	-	-	-	-	-	-	-	-	-	-	-
Milestones	-	-	-	-	-	-	-	$5.00M	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development Milestone Grant And Other Revenues Net	-	-	-	-	-	-	-	-	$2.50M	$4.80M	$1.70M	$3.80M	$2.10M	$2.30M	-	-	-	-	-	-
License And Service	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.92M	$1.53M

Cytokinetics's latest quarterly revenue breakdown by geography, as of Jun 23: Research And Development (100.00%).

Cytokinetics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
AMLX	Amylyx Pharmaceuticals	$380.79M	$416.00K
BPMC	Blueprint Medicines	$249.38M	$128.18M
ARVN	Arvinas	$78.50M	$102.40M
RLAY	Relay Therapeutics	$25.55M	-
RVMD	Revolution Medicines	$11.58M	-
STOK	Stoke Therapeutics	$8.78M	$4.89M
CYTK	Cytokinetics	$7.53M	$463.00K
PLRX	Pliant Therapeutics	$1.58M	-
BDTX	Black Diamond Therapeutics	-	-
XFOR	X4 Pharmaceuticals	-	$560.00K
ABOS	Acumen Pharmaceuticals	-	-
INZY	Inozyme Pharma	-	-
DYN	Dyne Therapeutics	-	-
TERN	Terns Pharmaceuticals	-	-
EWTX	Edgewise Therapeutics	-	-

CYTK Revenue FAQ

What is Cytokinetics’s yearly revenue?

Cytokinetics's yearly revenue for 2023 was $7.53M, representing a decrease of -92.04% compared to 2022. The company's yearly revenue for 2022 was $94.59M, representing an increase of 34.30% compared to 2021. CYTK's yearly revenue for 2021 was $70.43M, representing an increase of 26.15% compared to 2020.

What is Cytokinetics’s quarterly revenue?

Cytokinetics's quarterly revenue for Q3 2024 was $463K, a 85.94% increase from the previous quarter (Q2 2024), and a 22.49% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $249K, a -70.18% decrease from the previous quarter (Q1 2024), and a -71.28% decrease year-over-year (Q2 2023). CYTK's quarterly revenue for Q1 2024 was $835K, a -50.06% decrease from the previous quarter (Q4 2023), and a -81.90% decrease year-over-year (Q1 2023).

What is Cytokinetics’s revenue growth rate?

Cytokinetics's revenue growth rate for the last 3 years (2021-2023) was -89.31%, and for the last 5 years (2019-2023) was -71.97%.

What are Cytokinetics’s revenue streams?

Cytokinetics's revenue streams in c 23 are Research And Development, and Milestone. Research And Development generated $4.03M in revenue, accounting 53.52% of the company's total revenue, down -38.83% year-over-year. Milestone generated $3.5M in revenue, accounting 46.48% of the company's total revenue, up 250.00% year-over-year.

What is Cytokinetics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Cytokinetics was Research And Development. This segment made a revenue of $4.03M, representing 53.52% of the company's total revenue.